AngioDynamics Inc
Veridion Score
Composite trend over time
Why is ANGO moving today?
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ANGO.
ANGO insider activity
AngioDynamics Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$5K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2025-10-22 | 2025-10-21 | Weiss Lawrence T | Insider | buy | $11.81 | 10,000 | 93,597 | $118K | SEC Form 4 |
| 2025-10-14 | 2025-10-13 | Trowbridge Stephen A | Insider | buy | $11.16 | 890 | 256,629 | $10K | SEC Form 4 |
| 2025-10-09 | 2025-10-09 | Clemmer James C | Insider | buy | $11.15 | 10,000 | 882,529 | $112K | SEC Form 4 |
| 2025-07-22 | 2025-07-21 | Trowbridge Stephen A | Insider | sell | $8.99 | 667 | 255,739 | $6K | SEC Form 4 |
| 2025-07-22 | 2025-07-21 | Nighan Warren JR | Insider | sell | $8.99 | 277 | 69,903 | $2K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 14 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moANGO contract awards, year to date.
Public federal awards linked to this ticker.
ANGO lobbying filings, year to date.
Registered lobbying filings matched to AngioDynamics Inc.